Brokers

Search documents
GOHEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating GoHealth, Inc. on Behalf of GoHealth Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-09 01:00
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ:GOCO) on behalf of GoHealth stockholders. Our investigation concerns whether GoHealth has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On May 1, 2025, the U.S. Department of Justice ("DOJ") announced the fi ...
SLQT Investors Have Opportunity to Join SelectQuote, Inc. Fraud Investigation with the Schall Law Firm
Prnewswire· 2025-05-08 22:52
LOS ANGELES, May 8, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE: SLQT) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. SelectQuote is the subject of a DOJ False Claims Act filed on May 1, 2025. The f ...
IBKR Stock Gains on Higher April DARTs: Should You Buy, Hold, or Sell?
ZACKS· 2025-05-07 16:30
Core Viewpoint - Interactive Brokers Group, Inc. (IBKR) has reported a significant increase in client Daily Average Revenue Trades (DARTs) for April 2025, driven by higher net new accounts and increased trading activity in options and futures contracts [1][6]. Group 1: Financial Performance - Total client DARTs for April 2025 reached 3,818,000, marking a 63.2% increase compared to April 2024 [1]. - Following the DART announcement on May 1, IBKR shares rose by 2.3%, underperforming the industry but outperforming the Zacks Finance sector [2]. - The company’s net revenues have shown a compound annual growth rate (CAGR) of 21.8% over the last five years (2019-2024) [12]. Group 2: Market Conditions and Client Activity - IBKR has benefited from heightened market volatility and increased client activity due to tariff concerns and rising geopolitical risks [6]. - The momentum in client activity is expected to continue as markets react to tariff impacts across various sectors [6]. Group 3: Product Diversification and Global Expansion - IBKR has extended trading hours for its Forecast Contracts to nearly 24 hours a day, enhancing its trading income [7]. - The company has launched several initiatives, including the introduction of Plan d'Epargne en Actions accounts for French clients and the IBKR GlobalTrader mobile application for global stock trading [8][9]. - The expansion of investment offerings, including mutual funds in the U.K., aims to provide a tax-efficient savings vehicle for investors [7]. Group 4: Technological Advancements - IBKR's technological superiority allows it to process trades across more than 150 exchanges globally [11]. - The company has focused on developing proprietary software to automate broker-dealer functions, contributing to revenue growth [12]. - The introduction of IBKR Desktop marks a significant innovation in its trading platform [9]. Group 5: Valuation and Analyst Sentiment - IBKR shares are currently trading at a price-to-tangible book (P/TB) ratio of 1.12X, significantly below the industry average of 2.77X, indicating potential undervaluation [16]. - Despite a recent downward revision in earnings estimates for 2025 and 2026 by 3% and 3.2% respectively, the projected figures still imply growth [18][21]. - The company is well-positioned for growth in a volatile operating environment, supported by strong technological capabilities and diversified product offerings [22].
MarketAxess(MKTX) - 2025 Q1 - Earnings Call Transcript
2025-05-07 15:02
MarketAxess (MKTX) Q1 2025 Earnings Call May 07, 2025 10:00 AM ET Company Participants Stephen Davidson - Head - Investor RelationsChristopher Concannon - CEOIlene Fiszel Bieler - Chief Financial OfficerChristopher Allen - Managing DirectorAlex Kramm - Managing Director - Equity ResearchKyle Voigt - Managing Director - Equity ResearchChristopher O'Brien - Equity Research AVP - Brokers, Exchanges, & Asset ManagersBrian Bedell - Director Conference Call Participants Michael Cyprys - AnalystAlex Blostein - Ana ...
BGC(BGC) - 2025 Q1 - Earnings Call Transcript
2025-05-07 15:00
BGC Group (BGC) Q1 2025 Earnings Call May 07, 2025 10:00 AM ET Speaker0 Greetings, and welcome to the BGC Group First Quarter twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. And as a reminder, this conference is being recorded. It is now my pleasure to introduce to you Jason Kraseckis, Head of Investor Relations. You may begin. Speaker1 Thank you, and hello, everyone. This morning, we issued BGC's ...
SelectQuote (SLQT) Faces Investor Scrutiny After DOJ Alleges False Claims Act Violations – Hagens Berman
GlobeNewswire News Room· 2025-05-07 13:15
SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- On May 1, 2025, investors in SelectQuote (NYSE: SLQT) saw the price of their shares tumble over 19% after the U.S. Department of Justice announced it had filed a lawsuit against the company, other insurance brokers, and three of the nation's largest health insurance companies, claiming violations of the False Claims Act. Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now. The firm also encourages persons with kn ...
Kirby McInerney LLP Announces Investigation of Claims Against GoHealth, Inc. (GOCO) on Behalf of Investors
GlobeNewswire News Room· 2025-05-07 00:00
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ:GOCO). The investigation concerns whether GoHealth and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] On May 1, 2025, the U.S. Department of Justice filed a complaint against insurance broker organizations, including GoHealth ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT
Prnewswire· 2025-05-06 18:04
NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE: SLQT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On May 1, 2025, the U ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO
Prnewswire· 2025-05-06 18:04
NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. ("GoHealth" or the "Company") (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 1, 2025, the U.S. De ...
SELECTQUOTE ALERT: Bragar Eagel & Squire, P.C. is Investigating SelectQuote, Inc. on Behalf of SelectQuote Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-06 01:00
Core Viewpoint - The U.S. Department of Justice has filed a False Claims Act complaint against SelectQuote and other health insurance companies, alleging illegal kickbacks related to Medicare Advantage plans, leading to a significant drop in SelectQuote's stock price [2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against SelectQuote on behalf of its stockholders for possible violations of federal securities laws and unlawful business practices [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ lawsuit, SelectQuote's stock price decreased by $0.61 per share, representing a 19.24% decline, closing at $2.56 per share on May 1, 2025 [2].